Literature DB >> 24167698

Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report.

Jayaraman Hariram1, Yogaratnam Jegan.   

Abstract

Bipolar affective disorder is characterized by recurring episodes of mania with or without, but commonly with, episodes of depression. It usually begins in adolescence and can cause enduring and substantial impairment if left untreated. It needs a long-term treatment with mood stabilizers to prevent relapses. Elevated or depressed mood relapses can be either primary or secondary. However, primary mood relapses can occur without a significant precipitating factor, more often tending to occur following stressful life events or discontinuation of mood stabilizer medications. Secondary mood relapses can be caused by many conditions, such as physical illnesses, substance misuse and medications. When a mental illness coexists with another physical illness and the treatment of one complicates the other, it adds complexity to the selection of appropriate pharmacological regime for either condition. In this paper, the authors present a case of bipolar affective disorder who had two episodes of mania likely precipitated by methotrexate, which were reversed by the withdrawal of the offending drug (methotrexate). To the best of the authors' knowledge, to date there have been no published reports in the literature in which methotrexate, an immunosuppressive and a cytotoxic drug, precipitated a manic episode in a patient with bipolar affective disorder.

Entities:  

Keywords:  bipolar affective disorder; depression; mania; manic depressive illness; methotrexate; mood disorder

Year:  2013        PMID: 24167698      PMCID: PMC3805433          DOI: 10.1177/2045125313477103

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  15 in total

1.  Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.

Authors:  Wilfrid Jaksic; Dusan Veljkovic; Chris Pozza; Ian Lewis
Journal:  Acta Haematol       Date:  2004       Impact factor: 2.195

Review 2.  A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities.

Authors:  C T Quinn; B A Kamen
Journal:  J Investig Med       Date:  1996-12       Impact factor: 2.895

3.  Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex.

Authors:  Nikolaus Michael; Andreas Erfurth; Patricia Ohrmann; Michael Gössling; Volker Arolt; Walter Heindel; Bettina Pfleiderer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

4.  Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study.

Authors:  D R Copeland; B D Moore; D J Francis; N Jaffe; S J Culbert
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

5.  Plasma folate and affective morbidity during long-term lithium therapy.

Authors:  A Coppen; M T Abou-Saleh
Journal:  Br J Psychiatry       Date:  1982-07       Impact factor: 9.319

6.  Acute mania in the setting of severe hypothyroidism.

Authors:  Charles P Stowell; John W Barnhill
Journal:  Psychosomatics       Date:  2005 May-Jun       Impact factor: 2.386

Review 7.  Biochemical and clinical aspects of methotrexate neurotoxicity.

Authors:  Sandra Vezmar; Achim Becker; Udo Bode; Ulrich Jaehde
Journal:  Chemotherapy       Date:  2003-05       Impact factor: 2.544

8.  Anticancer agents are potent neurotoxins in vitro and in vivo.

Authors:  Wojciech Rzeski; Susanne Pruskil; Alexander Macke; Ursula Felderhoff-Mueser; Anne Katrin Reiher; Friederike Hoerster; Corina Jansma; Bozena Jarosz; Vanya Stefovska; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

Review 9.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

10.  Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.

Authors:  Sandra Vezmar; Patrick Schüsseler; Achim Becker; Udo Bode; Ulrich Jaehde
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

View more
  1 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.